To evaluate each individual, we take each training query, compute a ranking of images using the formula represented by the individual, and then compute the MAP results obtained in such ranking.
Using the formula for representing the mean cell survival curves for all the drugs along a common "ratio of AUC" axis, carboplatin, methotrexate and dactinomycin showed higher efficacy in comparison to RMAPC figures whereas the sensitivity order for the other drugs or for the group classifications did not change.
For a given histone modification type, the histone modification variation score (HMV) for a given TF in each of the 4 blood cell lineages was calculated using the formula: Ci represents a specific blood cell lineage and is characterized by discrete values for the three histone marks.
Then, the formula representing pump flowrate is deduced using a control volume approach.
The Weibull accelerated failure-time model was used to estimate the absolute CVD risk using the formula: were β0 represented the baseline BMI or WC coefficient, βj was the coefficient for covariates (BMI or WC and age), Xj represented the covariates, t=time and p=shape parameter.
Using the formula (2), we represent the dynamics equation for the BP in a pulsed magnetic field H y (t) = H0χ(1 − t/T) in the form m BP ∂ v / ∂ t + F ˜ = π 2 ΛΔ M S H y t (12).
Risk ratio estimates were finally derived using the formula, where d represents the average ambient concentration of the pollutant under study.
Tumor volume was calculated using the formula, 0.5ab, where a represent the larger and b represents the smaller of the two perpendicular indexes.
Fold change in gene expression was calculated using the formula 2-ΔΔCt and represented as relative expression after normalization to uninfected group.
With the TTO method, utility weights for states 'better than death' were calculated using the formula t/10, where t represented the number of years spent in the best imaginable health.
